BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 4862835)

  • 1. The effect of nicotinic acid on muscle blood flow in intermittent claudication measured with xenon-133 clearance method.
    Broomé A; Cederlund J; Eklöf B
    Scand J Clin Lab Invest Suppl; 1967; 99():233-40. PubMed ID: 4862835
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of peripheral arterial insufficiency with inositoli nicotinas (Hexanicit).
    Hentzer E
    Scand J Clin Lab Invest Suppl; 1967; 99():226-32. PubMed ID: 4862834
    [No Abstract]   [Full Text] [Related]  

  • 3. [Muscular clearance of xenon (Xe-133) as a measure of the effectiveness of Provasan and Bametan for the correction of blood flow in the lower limbs].
    Jonderko G; Szramek-Urbaniak A; Lewandowski J
    Pol Tyg Lek; 1981 Jan; 36(3):103-6. PubMed ID: 6113581
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of intermittent claudication with inositol nicotinate.
    Head A
    Practitioner; 1986 Jan; 230(1411):49-54. PubMed ID: 3513149
    [No Abstract]   [Full Text] [Related]  

  • 5. Does inositol nicotinate (Hexopal) influence intermittent claudication? A controlled trial.
    Kiff RS; Quick CR
    Br J Clin Pract; 1988 Apr; 42(4):141-5. PubMed ID: 3061427
    [No Abstract]   [Full Text] [Related]  

  • 6. Spontaneous recovery in intermittent claudication.
    Broomé A; Cederlund J; Eklöf B
    Scand J Clin Lab Invest Suppl; 1967; 99():157-9. PubMed ID: 6056914
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies of the effectivity of blood vessel-active drugs with 133Xe muscle clearance].
    Zerkowitz A; Hoppe G; Bublitz G
    Med Welt; 1969 Aug; 32():1736-40. PubMed ID: 5801059
    [No Abstract]   [Full Text] [Related]  

  • 8. The therapeutic efficacy of inositol nicotinate (Hexopal) in intermittent claudication: a controlled trial.
    O'Hara J; Jolly PN; Nicol CG
    Br J Clin Pract; 1988 Sep; 42(9):377-83. PubMed ID: 3075929
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
    Hansteen V; Lorentsen E
    Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison between the Xe-133 clearance method and occlusion plethysmography in man and direct blood flow measurement (drop recorder) in the isolated gastrocnemius cat muscle.
    Prerovský I; Kjellmer I; Tonnesen H; Lindbjerg I
    Scand J Clin Lab Invest Suppl; 1967; 99():18-23. PubMed ID: 6056922
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind placebo-controlled study of Hexopal in the treatment of intermittent claudication.
    O'Hara J
    J Int Med Res; 1985; 13(6):322-7. PubMed ID: 3908186
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study of various vasodilator agents by measuring the isotopic peripheral flow].
    Spach MO; Schwartz J
    Therapie; 1977; 32(3):301-8. PubMed ID: 337564
    [No Abstract]   [Full Text] [Related]  

  • 13. "Spontaneous course" of intermittent claudication.
    Johansson BW; Sievers J
    Scand J Clin Lab Invest Suppl; 1967; 99():156. PubMed ID: 4861916
    [No Abstract]   [Full Text] [Related]  

  • 14. The blood flow in calf muscles in normal man and in patients with obliterative arterial disease studied during walking by the Xe-133 clearance method.
    García del Río H
    Scand J Clin Lab Invest Suppl; 1967; 99():130-2. PubMed ID: 6056907
    [No Abstract]   [Full Text] [Related]  

  • 15. Skin and muscle flow during exercise in intermittent claudication.
    Koppelmann J
    Scand J Clin Lab Invest Suppl; 1973; 128():93-6. PubMed ID: 4764606
    [No Abstract]   [Full Text] [Related]  

  • 16. Xenon-133 clearance studies during walking; effect on muscle and skin blood flow; routine application with comment on branch thrombosis below the knee.
    Larsen OA
    Scand J Clin Lab Invest Suppl; 1973; 128():89-92. PubMed ID: 4587558
    [No Abstract]   [Full Text] [Related]  

  • 17. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S; Spinella G; Sciacchitanto D
    Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
    [No Abstract]   [Full Text] [Related]  

  • 18. Plethysmographic measurements of calf blood flow, and Xe-133 clearance from the calf muscle in patients with intermittent claudication.
    Hlavová A; Linhart J; Prerovský I; Oppelt A; Vavrejn B
    Cor Vasa; 1968; 10(2):99-109. PubMed ID: 5706099
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with new Cosaldon forms].
    Dammann C
    Med Klin; 1969 Feb; 64(8):344-8. PubMed ID: 5783023
    [No Abstract]   [Full Text] [Related]  

  • 20. The measurement of blood flow through muscle from the clearance of radioactive xenon.
    Bell G; Short DW
    Surg Gynecol Obstet; 1968 Jul; 127(1):61-5. PubMed ID: 5657783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.